Details of the Drug Combinations

General Information of This Drug (ID: DMYGEH7)

Drug Name

Ceftolozane sulfate DMYGEH7

Synonyms

Ceftolozane; CXA-101; CXA-301; CXA-301); Cephalosporin derivatives, Astellas; Cephalosporinderivatives, Calixa Therapeutics; FR-193879; FR-264205; FR-295389; CXA-101 (inhaled), Calixa; CXA-101 (inhaled), Cubist; Cephalosporin derivative (H pylori/P aeruginosa infection), Astellas; CXA-101 (inhaled, bacterial lung infection), Cubist

Indication

Disease Entry	ICD 11	Status	REF
Respiratory tract infection	CA45	Phase 4	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Tazobactam + Ceftolozane sulfate	DCN8W39	Tazobactam	Other Infectious Diseases	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02421120) Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT03485950) Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam